Health Vidya

To reduce the development of drug-resistant bacteria and maintain the effectiveness of sulfamethoxazole and trimethoprim tablets and other antibacterial drugs, sulfamethoxazole and trimethoprim tablets should be used only to treat or prevent infections that are proven or strongly suspected to be caused by susceptible bacteria. When culture and susceptibility information are available, they should be considered in selecting or modifying antibacterial therapy. In the absence of such data, local epidemiology and susceptibility patterns may contribute to empiric selection of therapy. For the treatment of urinary tract infections due to susceptible strains of the following organisms: species, species, and . It is recommended that initial episodes of uncomplicated urinary tract infections be treated with a single effective antibacterial agent rather than the combination. Urinary Tract Infections: Escherichia coli, Klebsiella Enterobacter Morganella morganii, Proteus mirabilis Proteus vulgaris For the treatment of acute otitis media in pediatric patients due to susceptible strains of or when in the judgment of the physician sulfamethoxazole and trimethoprim offers some advantage over the use of other antimicrobial agents. To date, there are limited data on the safety of repeated use of sulfamethoxazole and trimethoprim in pediatric patients under two years of age. Sulfamethoxazole and trimethoprim is not indicated for prophylactic or prolonged administration in otitis media at any age. Acute Otitis Media: Streptococcus pneumoniae Haemophilus influenzae For the treatment of acute exacerbations of chronic bronchitis due to susceptible strains of or when a physician deems that sulfamethoxazole and trimethoprim could offer some advantage over the use of a single antimicrobial agent. Acute Exacerbations of Chronic Bronchitis in Adults: Streptococcus pneumoniae Haemophilus influenzae For the treatment of enteritis caused by susceptible strains of and when antibacterial therapy is indicated. Shigellosis: Shigella flexneri Shigella sonnei For the treatment of documented pneumonia and for prophylaxis against pneumonia in individuals who are immunosuppressed and considered to be at an increased risk of developing pneumonia. Pneumocystis jiroveci Pneumonia: Pneumocystis jiroveci P. jiroveci P. jiroveci For the treatment of traveler's diarrhea due to susceptible strains of enterotoxigenic Traveler's Diarrhea in Adults: E. coli.